DVA

DaVita Inc.

$180.70

Current Price

All

AI analysis

Read what the AI thinks of DaVita Inc. in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

$12.21

P/E

13.4

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

After the close · Expected EPS: $3.61

Oct 23

Posts

Buffett's Berkshire Makes Google Its Third-Biggest Bet

Aug 17

Trade

About DaVita Inc.

DaVita runs a large network of outpatient kidney dialysis clinics across the United States and in several other countries, treating patients whose kidneys have failed and who need regular blood-filtering treatment to survive. The company makes money by billing Medicare, Medicaid and private insurers for each dialysis session, along with related lab work and kidney-care services.